ANGELA CAMPBELL: Open Payments
NPI 1114171956 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 40 payments from 13 companies in 2025. Trend: 2023 $409 · 2024 $1,233 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $295 |
| Janssen Pharmaceuticals, Inc | 3 | $187 |
| Teva Pharmaceuticals USA, Inc. | 7 | $179 |
| Gilead Sciences, Inc. | 1 | $122 |
| Neurocrine BioSciences, Inc. | 4 | $76 |
| Alkermes, Inc. | 3 | $60 |
| Lundbeck LLC | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: HETLIOZ, INVEGA SUSTENNA, UZEDY, Yeztugo, FANAPT, INGREZZA, REXULTI, ARISTADA.
Industry payments across KY — which companies pay providers there.
